Your browser doesn't support javascript.
loading
A case of antiphospholipid syndrome refractory to secondary anticoagulating prophylaxis after deep vein thrombosis-pulmonary embolism.
Gu, Kang Mo; Shin, Jong Wook; Park, In Won.
Affiliation
  • Gu KM; Division of Allergy and Pulmonary Medicine, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
  • Shin JW; Division of Allergy and Pulmonary Medicine, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
  • Park IW; Division of Allergy and Pulmonary Medicine, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Tuberc Respir Dis (Seoul) ; 77(6): 274-8, 2014 Dec.
Article in En | MEDLINE | ID: mdl-25580146
ABSTRACT
Antiphospholipid syndrome (APS) is an acquired systemic autoimmune disorder characterized by a combination of clinical criteria, including vascular thrombosis or pregnancy morbidity and elevated antiphospholipid antibody titers. It is one of the causes of deep vein thrombosis and pulmonary embolism that can be critical due to the mortality risk. Overall recurrence of thromboembolism is very low with adequate anticoagulation prophylaxis. The most effective treatment to prevent recurrent thrombosis is long-term anticoagulation. We report on a 17-year-old male with APS, who manifested blue toe syndrome, deep vein thrombosis, pulmonary thromboembolism, and cerebral infarction despite adequate long-term anticoagulation therapy.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Tuberc Respir Dis (Seoul) Year: 2014 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Tuberc Respir Dis (Seoul) Year: 2014 Document type: Article